Sign in

CIK 0001782303 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Boundless Bio, Inc.

Sign in to watch
Ticker
BOLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
830751369
Phone
(858) 766-9912
Business address
11099 NORTH TORREY PINES ROAD, SUITE 150, LA JOLLA, CA, 92037
  1. 4 Derivatives Options or other derivatives
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations · Regulation FD disclosure
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 4 Open-market buy Director bought 200,000 shares at $16.00 ($3,200,000)
  9. 4 Conversion Director acquired 525,274 shares (conversion)
  10. 4 Open-market buy 10% owner bought 200,000 shares at $16.00 ($3,200,000)
  11. 4 Open-market buy 10% owner bought 200,000 shares at $16.00 ($3,200,000)
  12. 4 Open-market buy 10% owner bought 312,500 shares at $16.00 ($5,000,000)
  13. 4 Conversion 10% owner acquired 556,233 shares (conversion)
  14. 8-K Event Bylaws or fiscal year change · Other events
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 9 · 164 filings